Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Dec 9;92:245. doi: 10.1016/j.bbi.2020.11.023

Corrigendum to “Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis” [Brain Behav. Immun. 88 (2020) 901–907]

Sofia Pappa a,b,⁎,1, Vasiliki Ntella c,1, Timoleon Giannakas c, Vassilis G Giannakoulis c, Eleni Papoutsi c, Paraskevi Katsaounou c,d
PMCID: PMC8445317  PMID: 33261973

The authors regret that a number of inaccuracies have been noted in Table 2 detailing the Modified Newcastle-Otawa Scale quality assessment scores. The study Huang J.Z. et al. had been taken into account during the quality assessment process and included in the original submission but was replaced by the word “Author” and some studies have changed order in the table during the production process. Furthermore, Du et al. and Zhang W. et al. were not assigned a star; with an additional star, Du et al. becomes low risk of bias whereas Zhang et al. remains low risk of bias. No star had been allocated in the original table for the response rate of Du et al. and this has been also rectified as shown in the corrected table below. The changes in the quality assessment score also affect the pooled estimates of low bias risk studies as Du et al. becomes low risk of bias. The adjusted low risk of bias values are 23.78% (instead of 24.06%) (95% CI 16.95%–31.34%, I2 = 99%) for Anxiety in 10 studies and 21.75% (instead of 22.93%), (95% CI 12.72%–32.34%, I2 = 99.62%) for Depression in 9 studies.

Table 2.

Modified Newcastle-Ottawa quality assessment scale and total score of each study.

Studies Year Modified Newcastle-Ottawa quality assessment scale
Score
1 2 3 4 5
Du et al. 2020 * * * 3
Guo et al. 2020 * * 2
Huang J.Z. et al. 2020 * * 2
Huang & Zhao 2020 * * * * 4
Lai et al. 2020 * * * * 4
Liu C. et al. 2020 * * * 3
Liu Z. et al. 2020 * * * 3
Lu et al. 2020 * * * 3
Qi et al. 2020 * * * * 4
Tan et al. 2020 * * * * 4
Zhang C. et al. 2020 * * * * 4
Zhang W. et al. 2020 * * * * 4
Zhu et al. 2020 * * * 3

1. Representativeness of sample (no HCWs’ subgroup ≥ 65% of total sample); 2. Sample size > 600 HCWs; 3. Response rate > 80%; 4. The study employed validate measurement tools with appropriate cut-offs; 5. Adequate statistics and no need for further calculations.

The authors would like to apologise for any inconvenience caused.


Articles from Brain, Behavior, and Immunity are provided here courtesy of Elsevier

RESOURCES